Crestmont Private Wealth LLC Laboratory Corp Of America Holdings Transaction History

Crestmont Private Wealth LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$209.01 - $232.56 $115,791 - $128,838	554 Added 37.03%	2,050 $448 Million
Q4 2023 Jan 11, 2024	SELL	$197.69 - $227.29 $2,767 - $3,182	-14 Reduced 0.93%	1,496 $340 Million
Q3 2023 Oct 11, 2023	SELL	$201.05 - $221.7 $80,420 - $88,680	-400 Reduced 20.94%	1,510 $304 Million
Q2 2023 Jul 07, 2023	BUY	$211.93 - $241.33 $39,207 - $44,646	185 Added 10.72%	1,910 $461 Million
Q1 2023 Apr 06, 2023	BUY	$213.32 - $257.83 $52,903 - $63,941	248 Added 16.79%	1,725 $396 Million
Q4 2022 Jan 06, 2023	BUY	$203.72 - $248.97 $300,894 - $367,728	1,477 New	1,477 $0

126

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $19.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Crestmont Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Crestmont Private Wealth LLC with notifications on news.